Thuja, Index invest €5.5m in Encare

Utrecht Holdings, the investment vehicle of University Medical Centre Utrecht and Utrecht University, also took part in the round.

Encare will use the fresh capital to develop a treatment for the prevention of chronic heart failure after a heart attack.

Thuja, a Utrecht-based venture capital firm that invests in early-stage healthcare companies in Belgium and the Netherlands, invested via its Thuja Capital Healthcare Seed Fund II.

Thuja is currently investing from its Thuja Capital Healthcare Fund II and Thuja Capital Healthcare Seed Fund II vehicles.

Company
Founded in 2014 as a spinout from University Medical Centre Utrecht, Encare is currently developing an antibody designed to help prevent heart failure after a heart attack (acute myocardial infarction).

People
Mark de Boer is the CEO of Encare. Index partner Michèle Ollier, Thuja managing partner Harrold van Barlingen and Utrecht Holdings managing director Oscar Schoots have all joined the company's supervisory board.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Early-stage
• Healthcare
• Netherlands